Sotera Health Company's stock plummeted 6.30% during Tuesday's intraday trading session, reversing from earlier gains following the release of its first-quarter financial results.

The company reported Q1 adjusted earnings per share of $0.18 and revenue of $280 million, both beating analyst expectations. However, a key miss in pretax profit, which came in at $42.613 million versus the IBES estimate of $71.5 million, triggered the sell-off. This substantial shortfall overshadowed other positive aspects of the report, including the reaffirmation of full-year guidance.

Concurrently, Sotera Health announced a planned leadership transition, with Alton Shader set to take over as chief executive on May 26, while current CEO Michael B. Petras, Jr. will move to the role of Executive Chairman. The combination of the pretax profit disappointment amid otherwise strong results and a leadership change contributed to the stock's volatility.